pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
SCIB-1
Metastatic Melanoma
Scancell Holdings Plc
0
catalysts
Phase 2
SCIB1 + iSCIB1+
Metastatic Melanoma
Scancell Holdings Plc
0
catalysts
Preclinical
SCO-155
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sun Pharma Advanced Research Company Ltd
0
catalysts
Phase 2
SENT-001
Fallopian Tube Cancer
← prev
page 33 of 62
next →
131
Pain
89
Neurology
1
Sentinel BioTherapeutics Inc
0
catalysts
Phase 1
SENTI-202
Myelodysplastic Syndrome (Preleukemia)
$SNTI
Senti Biosciences, Inc.
0
catalysts
Preclinical
SFA-001
Hepatocellular Carcinoma
SFA Therapeutics Inc
0
catalysts
Preclinical
SG-2901
Unspecified Cancer
Hangzhou Sumgen Biotech Co Ltd
0
catalysts
Phase 2
SGN-1
Metastatic Hepatocellular Carcinoma (HCC)
Guangzhou Huajin Pharmaceutical Technology Co Ltd
0
catalysts
Phase 1
SGR-1505
B-Cell Non-Hodgkin Lymphoma
$SDGR
Schrodinger, Inc.
0
catalysts
Phase 1
SGR-3515
Solid Tumor
$SDGR
Schrodinger, Inc.
0
catalysts
Phase 1
SH-3765
Non-Hodgkin Lymphoma
Nanjing Sanhome Pharmaceutical Co Ltd
0
catalysts
Phase 2
SHR-4849
Neuroendocrine Tumors
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 2
SI-101
Non-Hodgkin Lymphoma
BobcatBio Inc
0
catalysts
Preclinical
SIGX-2649
Solid Tumor
Signet Therapeutics (Shenzhen) Co Ltd
0
catalysts
Phase 1
SIM-0235
Metastatic Hepatocellular Carcinoma (HCC)
Simcere Pharmaceutical Group Ltd
0
catalysts
Phase 1
SIM-0500
Refractory Multiple Myeloma
Simcere Pharmaceutical Group Ltd
0
catalysts
Phase 1
SIM-0501
Solid Tumor
Simcere Pharmaceutical Group Ltd
0
catalysts
Phase 1
SIM-0505
Endometrial Cancer
$NXTC
NextCure, Inc.
0
catalysts
Phase 1
SIM-0508
Solid Tumor
Simcere Pharmaceutical Group Ltd
0
catalysts
Phase 1
SIM-0686
Solid Tumor
Simcere Pharmaceutical Group Ltd
0
catalysts
Phase 2
SL-701
Recurrent Glioblastoma Multiforme (GBM)
Stemline Therapeutics Inc
0
catalysts
Preclinical
SLATEV-3
Unspecified Cancer
Nexoplex Bio LLC
0
catalysts
Preclinical
SLEN-47
Solid Tumor
Gencirq Inc
0
catalysts
Phase 2
SMART-101
Refractory Acute Myeloid Leukemia
Smart Immune SAS
0
catalysts
Phase 2
SMP-3124
Anal Cancer
Sumitomo Pharma Co Ltd
0
catalysts
Phase 1
SNG-1153
Hepatocellular Carcinoma
Shenogen Pharma Group Ltd
0
catalysts
Preclinical
SNH-110
Unspecified Cancer
ScinnoHub Pharmaceutical Co Ltd
0
catalysts
Phase 1
SNK-02
Angiosarcoma
NKGen Biotech Inc
0
catalysts
Phase 1
SON-1010
Head And Neck Cancer
Sonnet BioTherapeutics Holdings Inc
0
catalysts
Phase 1
SORC-13
Adenoid Cystic Carcinoma (ACC)
Soricimed Biopharma Inc
0
catalysts
